Regional IL-2-based immunochemotherapy of colorectal liver metastases.
Okuno
K
K
First Department of Surgery, Kinki University School of Medicine, Osaka-sayama, Osaka, Japan. okuno@surg1.med.kindai.ac.jp
Kaneda
K
K
Yasutomi
M
M
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion; D015179:Colorectal Neoplasms / Q000473:pathology / Q000628:therapy*; D005472:Fluorouracil / Q000008:administration & dosage; D006498:Hepatectomy; D006499:Hepatic Artery; D006801:Humans; D007167:Immunotherapy; D007261:Infusions, Intra-Arterial; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000009:adverse effects; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D016685:Mitomycin / Q000008:administration & dosage; D051381:Rats; D011916:Rats, Inbred F344; D015996:Survival Rate
D007376:Interleukin-2; D016685:Mitomycin; D005472:Fluorouracil